SCHEMBL695828

SCHEMBL695828

Fc1ccc(-c2[nH]c3cc[c]cc3c2Cl)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 5/20 0.40
MAOA P21397 3/20 0.38
MAOB P27338 3/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
MAPK13 O15264 3/20 0.38
GCGR P47871 3/20 0.38
MAPK12 P53778 3/20 0.38
MAPK11 Q15759 3/20 0.38
PTGS2 P35354 3/20 0.37
SERPINE1 P05121 1/20 0.36
BCHE P06276 1/20 0.36
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36
FRK P42685 1/20 0.36
MAPK9 P45984 1/20 0.36
CSNK1A1 P48729 1/20 0.36
CSNK1D P48730 1/20 0.36
GSK3B P49841 1/20 0.36
PTK6 Q13882 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL694880 0.87 MAPK14 (0.42) MAPK14KDM4EMAPTMAPK13MAPK12
SCHEMBL4280065 0.83 MAOA (0.53) MAOAMAOBKDM4EMAPTDRD2
SCHEMBL694353 0.83 MAPK14 (0.39) MAPK14KDM4EMAPTPTGS2SERPINE1
SCHEMBL693599 0.80 MAPK14 (0.55) MAPK14MAOAMAOBKDM4EMAPT
SCHEMBL694066 0.73 ESR1 (0.46) MAPK14MAOAMAOBKDM4EMAPT
SCHEMBL695357 0.72 MAP2K4 (0.45) KDM4ECSNK1DHTR2AHTR2C
SCHEMBL21143005 0.69 NR4A2 (0.60) CLK4
SCHEMBL11330988 0.69 MAOA (0.44) MAOAMAOBKDM4EPTGS2
SCHEMBL11339598 0.69 MAOA (0.44) MAOAMAOBKDM4EMAPT
SCHEMBL852559 0.68 ALDH1A1 (0.39) KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197450-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2017-08-02 EP disclosed
WO-2016046130-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2016-03-31 WO disclosed
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP disclosed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO disclosed